(+) -JJ-74-138
(+) -JJ-74-138, a novel non-competitive androgen receptor (AR) antagonist, is capable of inhibiting Enzalutamide-resistant CRPC[1].
Product Specifications
CAS Number
[2135545-34-3]
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/plus-jj-74-138.html
Smiles
O=C(N1CCN(C2=CC(C(F)(F)F)=CC=C2C)CC1)[C@H]3[C@@H](C4=CC(S(F)(F)(F)(F)F)=CC=C4)C3
Molecular Formula
C22H22F8N2OS
Molecular Weight
514.48
References & Citations
[1] (+) -JJ-74-138 is a Novel Noncompetitive Androgen Receptor Antagonist. Mol Cancer Ther. 2022 Apr 1;21 (4) :483-492.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
251385-ML750 100 µL
S100A6 (S100 Calcium Binding Protein A6, 2A9, 5B10, CABP, CACY, PRA) (MaxLight 750) discontinued
Ask
View Details 
MBS1471322-01 0.02 mg (E-Coli)
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3), partial
Ask
View Details 
MBS1471322-02 0.1 mg (E-Coli)
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3), partial
Ask
View Details MBS1471322-03 1 mg (E-Coli)
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3), partial
Ask
View Details MBS1471322-04 5x 1 mg (E-Coli)
Recombinant Epstein-Barr virus Epstein-Barr nuclear antigen 3 (EBNA3), partial
Ask
View Details